NVST Envista Holdings Corp: רווח למניה ב-12 החודשים האחרונים

Envista Holdings (NVST) is changing its leadership to optimize operational processes and restore profitability. The strategy focuses on expanding premium implants, which is supported by comparable annual EPS TTM growth; the level of 4508.80 represents the current value of this metric. Business stability is ensured by plants in Europe and the US, leveraging global demand in dentistry.
פילוחי מדדים פיננסיים ומדדי שוק עבור Nobel Biocare (NVST)

For Envista Holdings (NVST), the trailing twelve-month EPS growth reflects the efficiency of monetizing a broad spectrum of dental solutions across the global market. This indicator captures the percentage change in net income per share over the last twelve months, confirming the business's ability to maintain profitability and withstand consumer demand volatility through product portfolio diversification.